Back to today’s briefing

Story perspectives

Mitsubishi Tanabe Pharma Sold to Bain Capital: Growth Concerns Rise

6/14/2025

23 4

Summary

Story summary

Mitsubishi Tanabe Pharma, Japan's oldest pharmaceutical company, is set to be sold to Bain Capital, marking a historic shift to foreign ownership. This strategic move, anticipated by September 2025, seeks to revitalize growth in a challenging domestic market. However, worries linger over Bain's focus on short-term profits potentially jeopardizing vital research and development efforts.

1 of 1

Story summary

Mitsubishi Tanabe Pharma, Japan's oldest pharmaceutical company, is set to be sold to Bain Capital, marking a historic shift to foreign ownership. This strategic move, anticipated by September 2025, seeks to revitalize growth in a challenging domestic market. However, worries linger over Bain's focus on short-term profits potentially jeopardizing vital research and development efforts.